share_log

Earnings Call Summary | Hydrofarm(HYFM.US) Q4 2023 Earnings Conference

Earnings Call Summary | Hydrofarm(HYFM.US) Q4 2023 Earnings Conference

業績電話會議摘要 | Hydrofarm (HYFM.US) 2023 年第四季度業績會議
富途資訊 ·  03/01 07:03  · 電話會議

The following is a summary of the Hydrofarm Holdings Group, Inc. (HYFM) Q4 2023 Earnings Call Transcript:

以下是 Hydrofarm Holdings Group, Inc. (HYFM) 2023年第四季度業績電話會議記錄摘要:

Financial Performance:

財務業績:

  • Hydrofarm reported positive adjusted EBITDA and positive free cash flow for the full year 2023 despite slight fall in sales due to US retail sector industry softness and regulatory challenges in US cannabis industry.

  • Improved profitability was noted in Q4 and full-year 2023 with increase in adjusted gross profit and adjusted gross profit margin.

  • Q4 and full-year sales grew for Hydrofarm's proprietary nutrient brands, contributing to profit.

  • Q4 net sales were down by 23.2% year-over-year, ending at $47.2 million due to a decrease in sales volume and price mix decline.

  • Q4 gross profit amounted to $8.4 million, showing a significant increase from previous year gross loss of $0.5 million.

  • Q4 selling, general, and administrative expense was less than the prior year, as was the adjusted EBITDA.

  • Hydrofarm ended the year with approximately $123 million of term debt, and around $102 million of net debt.

  • Hydrofarm報告稱,由於美國零售業疲軟和美國大麻行業的監管挑戰,銷售額略有下降,但2023年全年調整後的息稅折舊攤銷前利潤爲正,自由現金流爲正。

  • 隨着調整後的毛利和調整後的毛利率的增加,第四季度和2023年全年的盈利能力有所提高。

  • Hydrofarm專有營養素品牌的第四季度和全年銷售額均有所增長,爲利潤做出了貢獻。

  • 由於銷量減少和價格組合下降,第四季度淨銷售額同比下降23.2%,收於4,720萬美元。

  • 第四季度毛利爲840萬美元,較上年的50萬美元總虧損大幅增加。

  • 第四季度的銷售、一般和管理費用低於上一年,調整後的息稅折舊攤銷前利潤也低於上年。

  • Hydrofarm在年底擁有約1.23億美元的定期債務和約1.02億美元的淨負債。

Business Progress:

業務進展:

  • Initiatives such as restructuring, cost-saving, inventory reduction, better space utilization, and transportation and logistics cost reductions were executed, leading to profitability improvements.

  • The company experienced a geographical and product diversity increase in sales channels, with 25% of total 2023 sales coming from outside the US and Canada.

  • Hydrofarm plans for potential growth catalysts in 2024, including the federal descheduling of cannabis, the legalization of adult use cannabis in multiple US states, and legalization of recreational cannabis use in Germany.

  • Plans for 2024 include staying profitable while also improving sales, reducing inventory, and maintaining positive EBITDA.

  • The company aims to make improvements to their manufacturing facilities as part of their restructuring plan to enhance productivity and efficiency.

  • Full year 2024 aims include maintaining positive EBITDA, gross profit margins, and generating positive free cash flow, with an expectation of reduction in net sales in the low to high teens percentage-wise.

  • 實施了重組、節省成本、減少庫存、提高空間利用率以及降低運輸和物流成本等舉措,從而提高了盈利能力。

  • 該公司的銷售渠道的地域和產品多樣性有所增加,2023年總銷售額的25%來自美國和加拿大以外的地區。

  • Hydrofarm計劃在2024年開發潛在的增長催化劑,包括聯邦政府取消大麻的期限,美國多個州的成人用大麻合法化,以及德國將休閒大麻的使用合法化。

  • 2024年的計劃包括保持盈利,同時改善銷售,減少庫存和保持正的息稅折舊攤銷前利潤。

  • 該公司的目標是改善其製造設施,這是其重組計劃的一部分,以提高生產率和效率。

  • 2024年全年目標包括保持正的息稅折舊攤銷前利潤、毛利率和創造正的自由現金流,預計淨銷售額將按百分比從低到十幾歲之間下降。

More details: Hydrofarm IR

更多詳情: 水力農場 IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論